Answers are grounded in this paper and cite their sources.
Purpose To identify six-year fasting plasma glucose (FPG) trajectories among community-dwelling older adults with type 2 diabetes mellitus (T2DM) and to examine the associations between distinct trajectories and the risk of chronic diabetic complications. Methods This retrospective cohort study included 1,692 older adults with T2DM who received community-based health management in Kaiyang County, Guizhou Province, China, between 2019 and 2024 and had valid FPG monitoring data for six consecutive years. Group-based trajectory modelling (GBTM) was applied to identify long-term FPG trajectories. Multinomial logistic regression was used to determine factors associated with trajectory group membership, and Cox proportional hazards regression models were fitted to examine the associations between trajectory groups and the risk of chronic diabetic complications. Results Three distinct FPG trajectory groups were identified: a low-level stable group (86.3%), a high-level decreasing group (6.3%), and a high-level increasing group (7.4%). Compared with the low-level stable group, the high-level decreasing group was associated with a higher risk of chronic diabetic complications (HR = 2.17, 95% CI: 1.33–3.55), including diabetic eye disease (HR = 3.17, 95% CI: 1.57–6.39) and diabetic foot disease (HR = 5.92, 95% CI: 1.78–19.67). No significant association was observed between the high-level increasing group and the risk of chronic diabetic complications. Older age, central obesity, physical activity, and medication adherence were associated with FPG trajectory group membership. Conclusions Long-term FPG patterns exhibited substantial heterogeneity among community-dwelling older adults with T2DM. Despite a gradual decline in FPG levels over time, patients in the high-level decreasing group remained at increased risk of chronic diabetic complications. Long-term FPG trajectory analysis may help identify older adults with T2DM at high risk of complications in community settings and inform longitudinal glycaemic management and complication risk assessment.
No takes yet. Share an insight, caveat, or question.
Mo et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: